R&D Trends 2012
ReportsnReports.com have released a new market research report on “R&D Trends 2012″. It is not new news to anyone that R&D is at a cross roads. Pressure to reduce costs is being reflected in R&D and the drive to boost productivity continues. Externalization has become a solution for these R&D challenges. Companies seek saving by choosing to source their drug candidates via M&A, collaborations, licensing/co-development deals, venture capital investments, and partnerships with universities. This way they can share the cost and more importantly share the risk. Will this be the future of R&D? The downside to this will be pharma companies not risking it alone to combat niche areas and orphan drugs for rare conditions.
To purchase a report go to http://www.reportsnreports.com/reports/160648-rd-trends-2012.html.
To hear more about R&D challenges facing the pharma and biotech industry go to BioPharma Australasia